Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Balance Sheet

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	153.57	168.28	139.38	111.87	131.76	82.37
Short-Term Investments	-	-	-	-	15	-
Cash & Short-Term Investments	153.57	168.28	139.38	111.87	146.76	82.37
Cash Growth	15.49%	20.73%	24.59%	-23.77%	78.17%	-45.39%
Accounts Receivable	421.09	320.85	328.89	427.53	440.54	381.39
Other Receivables	3.32	0.92	0.35	50.33	45.53	1.23
Receivables	464.56	334.29	356.8	509.83	487.47	392.19
Inventory	552.91	465.59	401.77	333.41	281.22	331.4
Prepaid Expenses	0.6	0.26	0.25	-	-	0.37
Other Current Assets	106.3	88.67	89.72	-	-	37.73
Total Current Assets	1,278	1,057	987.92	955.11	915.46	844.06
Property, Plant & Equipment	553.32	453.82	249.24	211.12	150.41	141.46
Long-Term Investments	2.6	4.16	2.6	2.6	2.6	2.6
Other Intangible Assets	0.02	0.03	0.04	0.06	-	-
Other Long-Term Assets	-	0	-	-	-	-
Total Assets	1,834	1,515	1,240	1,169	1,068	988.13
Accounts Payable	358.93	237.09	224.39	142.9	235.93	224.94
Accrued Expenses	26.53	20.18	14.42	-	-	10.24
Short-Term Debt	6.5	-	56.66	-	-	0.51
Current Portion of Long-Term Debt	36.67	36.67	-	-	-	-
Current Income Taxes Payable	105.73	61.62	29.36	48.13	38.2	31.5
Other Current Liabilities	156.51	113.68	122.19	118.76	84.03	61.16
Total Current Liabilities	690.86	469.25	447.02	309.8	358.16	328.35
Long-Term Debt	140	163.33	68.76	-	-	-
Long-Term Leases	34.46	37.53	38.85	58.36	-	-
Long-Term Deferred Tax Liabilities	12.49	12.49	4.87	6.8	6.58	6.02
Other Long-Term Liabilities	0	-	-	-	-	-
Total Liabilities	877.81	682.6	559.5	374.95	364.74	334.38
Common Stock	149.34	149.34	149.34	149.34	149.34	119.48
Retained Earnings	668.91	543.76	383.26	488.51	398.33	387.3
Comprehensive Income & Other	137.83	139.39	147.7	156.09	156.06	146.98
Shareholders' Equity	956.08	832.49	680.31	793.94	703.73	653.76
Total Liabilities & Equity	1,834	1,515	1,240	1,169	1,068	988.13
Total Debt	217.62	237.53	164.27	58.36	-	0.51
Net Cash (Debt)	-64.05	-69.25	-24.88	53.52	146.76	81.86
Net Cash Growth	-	-	-	-63.53%	79.29%	-45.73%
Net Cash Per Share	-4.29	-4.64	-1.67	3.58	9.83	5.48
Filing Date Shares Outstanding	14.93	14.93	14.93	14.93	14.93	14.93
Total Common Shares Outstanding	14.93	14.93	14.93	14.93	14.93	14.93
Working Capital	587.09	587.84	540.89	645.31	557.29	515.71
Book Value Per Share	64.02	55.74	45.55	53.16	47.12	43.78
Tangible Book Value	956.06	832.46	680.26	793.88	703.73	653.76
Tangible Book Value Per Share	64.02	55.74	45.55	53.16	47.12	43.78
Land	0.4	0.4	0.4	0.4	0.4	-
Buildings	112.1	73.31	53.43	53.42	51.12	-
Machinery	508.19	395.9	291.46	250.9	244.46	-
Construction In Progress	181.49	212.7	114.11	81.88	75.24	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.